Nine of these genes (NLRP2, TP63, CYCS, CASP9, IL1A, CHMP2B, CHMP4C, CHMP3, and IL1B) were downregulated, while 32 genes (HMGB1, CHMP4B, IRF2, CHMP2A, CHMP6, TP53, GPX4, CASP3, PLCG1, NOD1, GSDMD, CASP8, IL18, CHMP4A, IRF1, BAX, NLRP1, CASP4, NLRP3, GSDMA, NLRP6, CASP1, NLRC4, GSDMB, PYCARD, GSDMC, NLRP7, NOD2, GZMB, CASP5, AIM2, and GZMA) were upregulated in cancer tissues. This evidence concerns the gene CASP9 and cancer.